Development of factor VIIa inhibitors as novel anticoagulants.

被引：0

作者：

Kolesnikov, A ^{[1
]}

Rai, R ^{[1
]}

Young, WB ^{[1
]}

Torkelson, S ^{[1
]}

Shrader, WD ^{[1
]}

Leahy, EM ^{[1
]}

Katz, BA ^{[1
]}

Sprengeler, PA ^{[1
]}

Liu, L ^{[1
]}

Mordenti, J ^{[1
]}

机构：

[1] Celera, San Francisco, CA 94080 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 227卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

351-MEDI

引用

页码：U71 / U71

页数：1

共 50 条

[21] Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa
Kranjc, A
Kikelj, D
Peterlin-Masic, L
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (32) : 4207 - 4227
[22] Development of factor VIIa inhibitors: Selectivity in trypsin family proteases
Shrader, WD
Costerison, J
Hendrix, J
Hu, HY
Kolesnikov, A
Kumar, V
Leahy, E
Rai, R
Shaghafi, M
Ton, T
Torkelson, S
Wesson, K
Young, WB
Katz, BA
Sprengeler, PA
Yu, C
Cabuslay, R
Gjerstad, E
Janc, J
Sanford, E
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U153 - U153
[23] Intracerebral Hemorrhagic Expansion Occurs in Patients Using Novel Anticoagulants.
Melmed, Kara R.
Lyden, Patrick
Moheet, Asma
STROKE, 2016, 47
[24] The present and future of oral anticoagulants.
Meschengieser, SS
Casais, P
Luceros, AS
Lazzari, MA
MEDICINA-BUENOS AIRES, 2000, 60 (01) : 139 - 142
[25] Development and Clinical Applications of Novel Oral Anticoagulants. Part I. Clinically Approved Drugs
Ahrens, Ingo
Peter, Karlheinz
Lip, Gregory Y. H.
Bode, Christoph
DISCOVERY MEDICINE, 2012, 13 (73) : 433 - 443
[26] Recollections on the discovery of factor VIIa as a novel therapeutic agent for hemophiliacs with inhibitors
Kisiel, W.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (07) : 1053 - 1056
[27] Development and Clinical Applications of Novel Oral Anticoagulants. Part II. Drugs Under Clinical Investigation
Ahrens, Ingo
Peter, Karlheinz
Lip, Gregory Y. H.
Bode, Christoph
DISCOVERY MEDICINE, 2012, 13 (73) : 445 - 450
[28] Neutral macrocyclic factor VIIa inhibitors
Wurtz, Nicholas R.
Parkhurst, Brandon L.
DeLucca, Indawati
Glunz, Peter W.
Jiang, Wen
Zhang, Xiaojun
Cheney, Daniel L.
Bozarth, Jeffrey M.
Rendina, Alan R.
Wei, Anzhi
Harper, Tim
Luettgen, Joseph M.
Wu, Yiming
Wong, Pancras C.
Seiffert, Dietmar A.
Wexler, Ruth R.
Priestley, E. Scott
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (12) : 2650 - 2654
[29] Design and synthesis of silanediol inhibitors of Factor XIa as novel anticoagulants
Duong, Hoan Q.
Sieburth, Scott Mcn.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[30] The quest for factor VIIa exosite inhibitors
Amour, A.
Hutchinson, J.
Avendano, A. M. Ruiz
Ratcliffe, S.
Alvarez, E.
Martin, J.
Toomey, J. R.
Senger, S.
Wolfeni, M.
Mooney, C.
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 555 - 558

← 1 2 3 4 5 →